Abstract
This study was undertaken to determine the association of inflammatory biomarker, oxidative stress and antioxidant capacity marker with fetal haemoglobin (HbF) level among sickle cell trait and sickle cell disease (SCD) patients in Chattisgarh. The study group consisted of 51 SCD (SS) patients with painful episode, 49 SCD (SS) patients with steady state, 50 sickle cell trait (AS) and 50 controls. Malondialdehyde (MDA), CRP, total antioxidant power (FARP), total thiol and HbF levels were quantified. We found a significant positive (p < 0.0001) association between CRP and MDA levels and its inverse association with HbF level in SS patients. We also observed that antioxidant capacity had significantly positively (p < 0.0001) associated with HbF level. The protective effect of HbF was found, because the increase in HbF levels resulted in decrease in lipid peroxidation and inflammation in SCD patients. A decrease in the HbF level and its antioxidant capacity has been associated with the pathogenesis of SCD. These finding may explain the high level of HbF is ameliorating oxidative stress and inflammation in SCD patients.
Similar content being viewed by others
References
Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH. Fetal haemoglobin in sickle cell anemia. Blood. 2011;118:19–27.
Sebastiani P, Wang L, Nolan VG, Melista E, Ma Q, Baldwin CT, Steinberg MH. Fetal hemoglobin in sickle cell anemia: Bayesian modelling of genetic associations. Am J Hematol. 2008;83:189–95.
Schnog JB, Mac Gillavry MR, Van Zanten AP, Meijers JC, Rojer RA, Duits AJ, Ten Cate H, Brandjes DP. Protein C and S and inflammation in sickle cell disease. Am J Hematol. 2004;76:26–32.
Chaves MAF, Leonart MSS, Nascimento AJD. Oxidative process in erythrocytes of individuals with haemoglobin S. Hematology. 2008;13:187–92.
Katz MA. The expanding role of oxygen free radicals in clinical medicine. West J Med. 1986;144:441–6.
Asian M, Thomley BD, Freeman BA. Reactive species in sickle cell disease. Ann N Y Acad Sci. 2000;899:375–91.
Johnson RM, Goyette G, Ravindranath Y, Ho YS. Hemoglobin autoxidation and regulation of endogenous H2O2 levels in erythrocytes. Free Radic Biol Med. 2005;39:1407–17.
Hebbel RP, Morgan WT, Eaton JW, Hedlund BE. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA. 1988;85:237–41.
Sheng K, Shariff M, Hebbel RP. Comparative oxidation of hemoglobins A and S. Blood. 1998;91:3467–70.
Dumaswala UJ, Zhuo L, Mahajan S, Nair PNM, Shertzer HG, Dibello P, Jacobsen DW. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. Am J Physiol Cell Physiol. 2001;280:C867–73.
Manfredimi V, Lazzaretti LL, Griebeler IH, Santin AP, Brandao VD, Wagner S. Blood antioxidant parameter in sickle cell anaemia patients in steady state. J Natl Med Assoc. 2008;100:897–902.
Tatum VL, Chow CK. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. Free Radic Res. 1996;25:133–9.
Dasgupta T, Fabry ME, Kaul DK. Antisickling property of fetal haemoglobin enhances nitric oxide bioavailability and ameliorates organ oxidative stress in transgenic-knockout sickle mice. Am J Physiol Regul Integr Comp Physiol. 2010;298:R394–402.
Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.
Lopez-Campos JL, Arellano E, Calero C, Delgado A, Marquez E, Cejudo P, Ortega F, Rodriguez-Panadero F, Montes-Worboys A. Determination of inflammatory biomarkers in patients with COPD: a comparison of different assays. BMC Med Res Methodol. 2012. doi:10.1186/1471-2288-12-40.
Benzie FFI, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “Antioxidant Power”: the FRAP assay. Anal Biochem. 1996;239:70–6.
Hu ML, Dillard CJ. Plasma SH and GSH measurement. Methods Enzymol. 1994;233:385–7.
Walter BP, Fung BE, Killilea WD, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. Oxidative stress and inflammation in iron-overloaded patients with β-thalassaemia or sickle cell disease. Br J Haematol. 2006;135:254–63.
Akohoue SA, Shankar S, Milne GL, Morrow J, Chen KY, Ajayi WU, Buchowski MS. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res. 2007;61:233–8.
Bourantas KL, Dalekos GN, Makis A, Chaidos A, Tsiara S, Mavridis A. Acute phase proteins and interleukins in steady state sickle cell disease. Eur J Haematol. 1998;61:49–54.
Hedo CC, Aken’ova YA, Okpala IE, Durojaiye AO, Salimonu LS. Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med. 1993;233:467–70.
Hebbel RP, Eaton IW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Investig. 1982;70:1253–9.
Titus J, Chari S, Gupta M, Prakash N. Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia. Indian J Clin Biochem. 2004;19:168–72.
Platt OS. Sickle cell anemia as an inflammatory disease. J Clin Investig. 2000;106:337–8.
Mohammed FA, Mahdi N, Sater MA, Al-Ola K, Almawi WY. The relation of C-reactive protein to vasoocclusive crisis in children with sickle cell disease. Blood Cells Mol Dis. 2010;45:293–6.
Das SK, Nair R. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol. 1980;44:87–91.
Jain SK. The accumulation of malondialdehyde, a product of fatty acid peroxidation can disturb amino-phospholipid organization in the membrane bilayer of human erythrocytes. J Biol Chem. 1984;259:3391–4.
Capo C, Bongrand P, Benoliel AM, Depieds R. Non-specific recognition in phagocytosis: ingestion of aldehyde treated erythrocytes by rat peritoneal macrophages. Immunology. 1979;36:501–8.
Hundekar PS, Suryakar AN, Karnik AC, Valvi R, Ghone RA, Bhagat SS. The effect of antioxidant supplementation on the oxidant and antioxidant status in sickle cell anaemia. J Clin Diagn Res. 2011;5:1339–42.
Fasola F, Adedapo K, Anetor J, Kuti M. Total antioxidants status and some haematological values in sickle cell disease patients in steady state. J Natl Med Assoc. 2007;99:891–4.
Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J, Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA. 2003;289:1645–51.
Charache S. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults. Semin Hematol. 1997;34:15–21.
Kaul DK, Liu XD, Chang HY, Nagel RL, Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Investig. 2004;114:1136–45.
Silva DG, Belini Junior E, Torres Lde S, Ricci Júnior O, Lobo Cde C, Bonini-Domingos CR, de Almeida EA. Relationship between oxidative stress, glutathione S-transferase polymorphisms and hydroxyurea treatment in sickle cell anemia. Blood Cells Mol Dis. 2011;47:23–8.
Teixeira Neto PF, Goncalves RP, Elias DB, Araujo CP, Magalhaes HI. Analysis of oxidative status and biochemical parameters in adult patients with sickle cell anemia treated with hydroxyurea, Ceara, Brazil. Rev Bras Hematol Hemoter. 2011;33:207–10.
Acknowledgments
The authors are thankful to all the donors of blood samples for the present study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bhagat, S., Patra, P.K. & Thakur, A.S. Association of Inflammatory Biomarker C-Reactive Protein, Lipid Peroxidation and Antioxidant Capacity Marker with HbF Level in Sickle Cell Disease Patients from Chattisgarh. Ind J Clin Biochem 27, 394–399 (2012). https://doi.org/10.1007/s12291-012-0231-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-012-0231-x